Advancements in Hydrogel-Based Drug Sustained Release Systems for Bone Tissue Engineering
Bone defects caused by injury, disease, or congenital deformity remain a major health concern, and efficiently regenerating bone is a prominent clinical demand worldwide. However, bone regeneration is an intricate process that requires concerted participation of both cells and bioactive factors. Mim...
Main Authors: | Yunfan Zhang, Tingting Yu, Liying Peng, Qiannan Sun, Yan Wei, Bing Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00622/full |
Similar Items
-
Composite Hydrogels with the Simultaneous Release of VEGF and MCP-1 for Enhancing Angiogenesis for Bone Tissue Engineering Applications
by: Lei Nie, et al.
Published: (2018-12-01) -
Bone Tissue Engineering
by: Pinar Yilgor Huri, et al.
Published: (2010-08-01) -
The Delivery of RNA-Interference Therapies Based on Engineered Hydrogels for Bone Tissue Regeneration
by: Tingting Yu, et al.
Published: (2020-05-01) -
A Tetra-PEG Hydrogel Based Aspirin Sustained Release System Exerts Beneficial Effects on Periodontal Ligament Stem Cells Mediated Bone Regeneration
by: Yunfan Zhang, et al.
Published: (2019-10-01) -
Hydrogel Encapsulation of Mesenchymal Stem Cells and Their Derived Exosomes for Tissue Engineering
by: Parisa Khayambashi, et al.
Published: (2021-01-01)